Black individuals may be at higher risk for attention-deficit/hyperactivity disorder than the general US population.
An increased risk of ADHD-related behaviors was associated with exposure to select phthalates. Associations were strongest for phthalates with antiandrogenic activity.
SHP465 mixed amphetamine salts reduced symptoms of attention-deficit/hyperactivity disorder in adults, independent of ADHD treatment history.
A retrospective study was conducted to evaluate the demographic predictors of ADHD in hospitalized children with ASD and the impact of comorbidities on length of stay.
Investigators conducted a randomized clinical trial to assess the safety and efficacy of the investigational stimulant AR19 for the treatment of symptoms of attention-deficit/hyperactivity disorder in adults.
The combined burden of ADHD and insomnia may play a unique role in mental functioning and productivity, even after adjustment for other psychiatric comorbidities.
Children in grandparent-led households are much more likely to have a history of adverse childhood experiences.
Despite being common and often comorbid neurodevelopmental disorders, the study found robust yet subtle differences across age groups and the disorders in terms of cortical and subcortical brain structures.
Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.
The researchers concluded that the correlation between interregional cortical thinning during maturation and expression patterns of genes associated with multiple psychiatric disorders suggested a common molecular process.